4.0
Dec 11, 2024
Current employee, less than 1 year
Burlingame, CA
Recommend
CEO approval
Business outlook
Pros
Product makes a positive impact on improving clinical, operational, and financial outcomes
Cons
Selling disruptive technology is challenging!